Asahi Kasei Pharma
Corporate Profile
We are growing as a specialty pharmaceutical firm with a global presence by focusing on the development of new world-class drugs in the areas of pain management, musculoskeletal disorders, and critical care medicine. In diagnostics, management resources are concentrated on products with strong growth prospects.
| Trade name | Asahi Kasei Pharma Corp. |
|---|---|
| Main businesses | Pharmaceuticals, diagnostic reagents |
| Home office | Hibiya Mitsui Tower, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006 Japan |
| President | Yoshikazu Aoki |
| Paid-in capital | ¥3,000 million |
| Shareholder | Asahi Kasei Corp. |
| Phone | +81-(0)3-6699-3600 |
(as of April 1, 2020)
Officers
| Yoshikazu Aoki | President & Representative Director, Presidential Executive Officer |
|---|---|
| Fumiaki Hamada | Director, Senior Executive Officer |
| Yasuo Nakamura | Director, Executive Officer |
| Masato Kashiwagi | Executive Officer |
| Takeshi Ohno | Executive Officer |
| Kenji Suehiro | Corporate Auditor |
(as of April 1, 2024)
Major Subsidiaries and Affiliates
China
| Asahi Kasei Pharma (Beijing) Co., Ltd. | Regulatory affairs and business support in China +86-10-6569-3939 |
|---|